When did PEDIATRIX MEDICAL GROUP INC (MD) report earnings last quarter?
PEDIATRIX MEDICAL GROUP INC (MD) last reported earnings on 2/19/2026.
PEDIATRIX MEDICAL GROUP INC (MD) Earnings History & Surprises
NYSE:MD • US58502B1061
Current stock price
21.18 USD
+0.48 (+2.32%)
At close:
21.18 USD
0 (0%)
After Hours:
MD Earnings overview
Past quarterly earnings results for PEDIATRIX MEDICAL GROUP INC (MD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.39
- Revenue Estimate
- 479.66M
Last Reported
Most Recent- Release Date
- Feb 19, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.50
- EPS Surprise
- -9.94%
- Revenue Surprise
- -1.41%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.50 | 0.56 | -9.94% | -1.96% | 493.771M | 500.81M | -1.41% | -1.71% |
| Q3 2025 | 0.67 | 0.48 | 39.68% | 52.27% | 492.875M | 490.79M | 0.42% | -3.58% |
| Q2 2025 | 0.53 | 0.44 | 21.14% | 55.88% | 468.844M | 478.25M | -1.97% | -7.03% |
| Q1 2025 | 0.33 | 0.25 | 32.73% | 65.00% | 458.359M | 465.04M | -1.44% | -7.42% |
| Q4 2024 | 0.51 | 0.38 | 34.96% | 59.38% | 502.364M | 500.79M | 0.31% | 1.19% |
| Q3 2024 | 0.44 | 0.38 | 15.90% | 37.50% | 511.158M | 513.83M | -0.52% | 0.90% |
| Q2 2024 | 0.34 | 0.32 | 5.21% | -12.82% | 504.296M | 520.66M | -3.14% | 0.74% |
| Q1 2024 | 0.20 | 0.19 | 4.25% | -13.04% | 495.101M | 514.05M | -3.69% | 0.83% |
| Q4 2023 | 0.32 | 0.33 | -4.41% | -31.91% | 496.443M | 539.04M | -7.90% | -3.39% |
| Q3 2023 | 0.32 | 0.45 | -28.23% | -20.00% | 506.612M | 523.5M | -3.23% | 3.41% |
| Q2 2023 | 0.39 | 0.41 | -5.81% | -17.02% | 500.577M | 510.73M | -1.99% | 2.99% |
| Q1 2023 | 0.23 | 0.24 | -2.38% | -30.30% | 491.008M | 505.5M | -2.87% | 1.82% |
| Q4 2022 | 0.47 | 0.50 | -5.68% | -9.62% | 513.844M | 517.05M | -0.62% | 3.07% |
| Q3 2022 | 0.40 | 0.56 | -29.04% | -13.04% | 489.915M | 527.11M | -7.06% | -0.62% |
| Q2 2022 | 0.47 | 0.49 | -4.02% | 14.63% | 486.033M | 506.28M | -4.00% | 2.76% |
| Q1 2022 | 0.33 | 0.28 | 17.55% | 37.50% | 482.229M | 488.42M | -1.27% | 7.93% |
| Q4 2021 | 0.52 | 0.45 | 15.71% | 108.00% | 498.53M | 498.34M | 0.04% | 19.67% |
| Q3 2021 | 0.46 | 0.43 | 7.43% | 24.32% | 492.949M | 494.45M | -0.30% | 7.02% |
| Q2 2021 | 0.41 | 0.33 | 22.72% | 28.12% | 472.959M | 462.41M | 2.28% | 13.86% |
| Q1 2021 | 0.24 | 0.14 | 75.63% | -25.00% | 446.8M | 436.85M | 2.28% | 1.27% |
| Q4 2020 | 0.25 | 0.37 | -31.88% | - | 416.6M | 473.33M | -11.99% | - |
| Q3 2020 | 0.37 | 0.42 | -10.88% | - | 460.6M | 551.45M | -16.47% | - |
| Q2 2020 | 0.32 | 0.09 | 248.30% | - | 415.4M | 572.6M | -27.45% | - |
| Q1 2020 | 0.32 | 0.56 | -42.56% | - | 441.2M | 878.02M | -49.75% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
20.90%
Max EPS beat (4)
39.68%
Min EPS beat (4)
-9.94%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-1.10%
Max Revenue beat (4)
0.42%
Min Revenue beat (4)
-1.97%
Analysis
In the last 4 quarters, MD has beaten EPS estimates in 3 out of 4 releases
MD has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, MD has beaten the EPS estimates by 20.9% on average.
In the last 4 quarters, MD reported -1.1% below the revenue estimates on average.
Related analysis
PEDIATRIX MEDICAL GROUP INC / MD Earnings FAQ
Can you provide information on whether PEDIATRIX MEDICAL GROUP INC beat earnings estimates in the last quarter?
PEDIATRIX MEDICAL GROUP INC (MD) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often PEDIATRIX MEDICAL GROUP INC beats earnings estimates?
In the last 4 quarters, PEDIATRIX MEDICAL GROUP INC (MD) has beaten EPS estimates in 3 out of 4 releases.